Wen‐Ze Qiu

1.1k total citations
34 papers, 578 citations indexed

About

Wen‐Ze Qiu is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Wen‐Ze Qiu has authored 34 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Otorhinolaryngology, 16 papers in Oncology and 15 papers in Surgery. Recurrent topics in Wen‐Ze Qiu's work include Head and Neck Cancer Studies (27 papers), Head and Neck Surgical Oncology (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Wen‐Ze Qiu is often cited by papers focused on Head and Neck Cancer Studies (27 papers), Head and Neck Surgical Oncology (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Wen‐Ze Qiu collaborates with scholars based in China and United States. Wen‐Ze Qiu's co-authors include Xiang Guo, Xing Lv, Hu L, Guoying Liu, Yawei Yuan, Yan‐Qun Xiang, Wei‐Xiong Xia, Chong Zhao, Kajia Cao and Junli Shi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Wen‐Ze Qiu

33 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen‐Ze Qiu China	14	247	227	155	147	135	34	578
Jana Halámková Czechia	10	155 0.6×	191 0.8×	110 0.7×	191 1.3×	108 0.8×	36	553
Marco Siano Switzerland	15	105 0.4×	297 1.3×	93 0.6×	175 1.2×	153 1.1×	43	639
Begoña Jiménez Spain	15	43 0.2×	272 1.2×	53 0.3×	176 1.2×	116 0.9×	29	531
Beatriz Cirauqui Spain	13	101 0.4×	357 1.6×	71 0.5×	108 0.7×	197 1.5×	56	549
Greg Dyson United States	13	32 0.1×	192 0.8×	56 0.4×	219 1.5×	172 1.3×	36	561
Baolin Qu China	13	64 0.3×	60 0.3×	57 0.4×	107 0.7×	157 1.2×	74	464
Yingying Huang China	9	75 0.3×	106 0.5×	42 0.3×	106 0.7×	60 0.4×	30	326
Howard Liu Australia	13	124 0.5×	202 0.9×	116 0.7×	109 0.7×	198 1.5×	43	555
Xinqiong Huang China	11	62 0.3×	111 0.5×	40 0.3×	171 1.2×	45 0.3×	18	347
Tetsuya Urasaki Japan	12	33 0.1×	205 0.9×	99 0.6×	73 0.5×	107 0.8×	53	416

Countries citing papers authored by Wen‐Ze Qiu

Since Specialization

Citations

This map shows the geographic impact of Wen‐Ze Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Ze Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Ze Qiu more than expected).

Fields of papers citing papers by Wen‐Ze Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Ze Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Ze Qiu. The network helps show where Wen‐Ze Qiu may publish in the future.

Co-authorship network of co-authors of Wen‐Ze Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Ze Qiu. A scholar is included among the top collaborators of Wen‐Ze Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Ze Qiu. Wen‐Ze Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Yishu, Yingying Huang, Haijun Wu, et al.. (2025). Establishment of a deep-learning-assisted recurrent nasopharyngeal carcinoma detecting simultaneous tactic (DARNDEST) with high cost-effectiveness based on magnetic resonance images: a multicenter study in an endemic area. Cancer Imaging. 25(1). 39–39.

Tian, Yunhong, Zhong Huang, Jie Lin, et al.. (2024). Neoadjuvant docetaxel-cisplatin followed by concurrent chemoradiotherapy and adjuvant tislelizumab for locally advanced nasopharyngeal carcinoma: A multicenter, single-arm, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). e18047–e18047. 1 indexed citations

Cao, Xun, Yingying Huang, Ying Deng, et al.. (2024). Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence area. Radiotherapy and Oncology. 197. 110324–110324. 6 indexed citations

Deng, Yishu, Yingying Huang, Bingzhong Jing, et al.. (2023). Deep learning-based recurrence detector on magnetic resonance scans in nasopharyngeal carcinoma: A multicenter study. European Journal of Radiology. 168. 111084–111084. 4 indexed citations

Huang, Yingying, Jiayu Zhou, Ying Deng, et al.. (2023). Integrated strategies for chemotherapy cycles in nasopharyngeal carcinoma patients: Real-world data from two epidemic centers guiding decision-making. Chinese Journal of Cancer Research. 35(2). 126–139. 3 indexed citations

Chen, Dongni, Wen‐Ze Qiu, Yingying Huang, et al.. (2022). Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis. Journal of Cancer Research and Clinical Oncology. 149(6). 2327–2344. 10 indexed citations

Khan, Muhammad, Mei-Ling Ai, Kunpeng Du, et al.. (2022). Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective. Frontiers in Immunology. 13. 1062225–1062225. 38 indexed citations

Yuan, Yawei, et al.. (2022). The Prognostic Impact of Combined Tumor-Infiltrating Lymphocytes and Pretreatment Blood Lymphocyte Percentage in Locally Advanced Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 788497–788497. 7 indexed citations

Zhang, Fang, et al.. (2021). The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis. Frontiers in Immunology. 12. 719650–719650. 3 indexed citations

10.

Li, Wang‐Zhong, Guoying Liu, Shu‐Hui Lv, et al.. (2020). MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it. Radiotherapy and Oncology. 145. 101–108. 14 indexed citations

11.

Qiu, Wen‐Ze, Zhongyuan Liu, Rui-Xin Zhang, et al.. (2020). Clinical value of nedaplatin-based chemotherapy combined with radiotherapy for locoregional advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis. Journal of Cancer. 11(23). 6782–6789. 7 indexed citations

12.

Qiu, Wen‐Ze, et al.. (2020). Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma. Journal of Cancer. 12(1). 18–27. 8 indexed citations

13.

Zheng, Jieling, Baiyao Wang, Rong Zheng, et al.. (2020). Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells. Cell Death and Disease. 11(9). 758–758. 45 indexed citations

14.

Jing, Bingzhong, Tao Zhang, Zixian Wang, et al.. (2019). A deep survival analysis method based on ranking. Artificial Intelligence in Medicine. 98. 1–9. 54 indexed citations

15.

Qiu, Wen‐Ze, Haibo Zhang, Jing Yang, et al.. (2018). The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling. Journal of Experimental & Clinical Cancer Research. 37(1). 85–85. 40 indexed citations

16.

Yu, Ya‐Hui, Liang‐Ru Ke, Xing Lv, et al.. (2018). The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma. Cancer Management and Research. Volume 10. 1935–1946. 37 indexed citations

17.

Yu, Ya‐Hui, Hu L, Xing Lv, et al.. (2018). Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area. Journal of Cancer Research and Clinical Oncology. 144(11). 2231–2243. 7 indexed citations

18.

L, Hu, Yan‐Qun Xiang, Xing Lv, et al.. (2017). Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area. European Journal of Cancer. 73. 48–60. 34 indexed citations

19.

Ke, Liang‐Ru, Wei‐Xiong Xia, Wen‐Ze Qiu, et al.. (2017). A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma. Oral Oncology. 70. 7–13. 15 indexed citations

20.

Ke, Liang‐Ru, Wei‐Xiong Xia, Wen‐Ze Qiu, et al.. (2017). Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial. BMC Cancer. 17(1). 134–134. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact